In a study published in Nature Medicine, an interdisciplinary team of researchers from The Westmead Institute for Medical Research (WIMR) and the Sydney Precision Data Science Centre at the University of Sydney have, for ...
Jun 18, 2024
0
23
Investigators from Northwestern University Feinberg School of Medicine and The University of Texas MD Anderson Cancer Center have discovered that using a novel drug to target the STING pathway in glioblastoma reprogrammed ...
Jun 18, 2024
0
6
Autoimmune diseases cannot currently be cured, only treated, and this is also true for neuromyelitis optica spectrum disorder, which affects the central nervous system. A Kobe University study of how the treatment acts on ...
Jun 18, 2024
0
23
In our fast-paced world, convenience can often come at the cost of nutrition. This shift has led to an increased reliance on ultra-processed foods.
Jun 18, 2024
0
17
Lebrikizumab is associated with sustained effects for moderate-to-severe atopic dermatitis for up to week 52 following withdrawal of treatment, according to a study presented at the annual Revolutionizing Atopic Dermatitis ...
Jun 18, 2024
0
0
The prevalence of allergic diseases has been increasing globally, posing significant public health challenges. Allergic reactions can range from mild, such as allergic rhinitis (AR) and conjunctivitis, to severe, like allergic ...
Jun 18, 2024
0
57
The sites where our bodies come into contact with the outside world—via skin, the surface of the eye, inside the mouth, the lining of the intestine and the urinary tract, for example—are known as barrier tissues.
Jun 17, 2024
0
64
The course of SARS-CoV-2 coronavirus infections depends not only on how aggressive the virus is, but also on the immune response of the infected individual. Using single-cell analyses, a group of researchers led by Samantha ...
Jun 17, 2024
0
35
A study from physician-scientists at the Hospital for Special Surgery (HSS) points to a potential novel approach for treating autoimmune diseases like rheumatoid arthritis—preventing antibodies and immune cells from leaving ...
Jun 17, 2024
0
50
The risk of secondary cancer after CAR-T therapy, pioneered at Penn, is less than regulators feared last year, an FDA official said June 14 at cell and gene therapy conference in King of Prussia.
Jun 17, 2024
0
2
